内镜检查前使用胰高血糖素样肽受体激动剂与低胃内容物残留相关:一项多中心横断面分析
这项多中心横断面研究纳入2021至2023年使用胰高血糖素样肽受体激动剂(GLP1-RAs)并接受内镜检查的815例患者,评估胃内容物残留情况。8.7%患者有胃内容物残留,其中93%为2型糖尿病;按美国麻醉医师学会(ASA)指导停药者残留率较低(4.4% vs 12.7%,P < 0.001)。作者认为应采取个体化策略而非普遍术前停药。
要点
- 使用GLP1-RAs患者内镜下胃内容物残留率为8.7%,多数(93%)为2型糖尿病患者。
- 按ASA指导停药者胃内容物残留率4.4%,未按指导停药者12.7%(P < 0.001)。
- 糖化血红蛋白每升高1%,食物残留可能性增加36%(95%CI 1.15-1.60)。
核心结论
- 使用GLP1-RAs患者内镜检查中胃内容物残留率很低,且大多为2型糖尿病患者。
- 研究结果提示应采取个体化方法,而非普遍术前停药。
研究设计与样本
- 多中心横断面研究,纳入2021至2023年确认使用GLP1-RAs并接受内镜检查的患者815例。
- 收集人口学、处方实践和操作结局,按ASA指导回顾性分类术前停药管理,采用多因素logistic回归分析影响胃内容物残留的因素。
主要发现
- 815例患者中70例(8.7%)内镜下见胃内容物残留,其中65例(93%)为2型糖尿病。
- 仅1例(1.4%)需非计划插管,无 aspiration 事件。
- 按ASA指导停药者(406例,49.8%)胃内容物残留率较低(4.4% vs 12.7%,P < 0.001)。
- 因胃内容物残留导致的插管率(0% vs 2%,P = 0.53)或中止操作率(28% vs 18%,P = 0.40)无显著差异。
- 多因素分析中,调整GLP1-RA类型和术前停药后,糖化血红蛋白每升高1%,食物残留可能性增加36%(95%CI 1.15-1.60)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: While ubiquity of glucagon-like peptide receptor agonists (GLP1-RAs) is rising, guidance from the gastroenterology societies and American Society of Anesthesiologist (ASA) remains in conflict on recommendations regarding preoperative holding before endoscopy. The aim of this study was to address this by evaluating the effect of GLP1-RAs on gastric retention during upper endoscopy. METHODS: This multicenter cross-sectional study included patients on confirmed GLP1-RAs receiving an endoscopy from 2021 to 2023. Demographics, prescribing practices, and procedure outcomes were captured. GLP1-RA management of preoperative holding was retroactively classified per ASA guidance. Multivariable logistic regression was performed to assess factors influencing retained gastric contents. RESULTS: Of 815 patients, 70 (8.7%) had retained gastric contents on endoscopy of whom 65 (93%) had type 2 diabetes mellitus. Only 1 (1.4%) of these patients required unplanned intubation, and none had aspiration events. Those with GLP1-RA held per ASA guidance (406, 49.8%) were less likely to have retained contents (4.4% vs 12.7%, P < 0.001), but there were no significant differences to intubation (0% vs 2%, P = 0.53) or aborting procedure rates (28% vs 18%, P = 0.40) due to gastric retention. On multivariable analysis, likelihood of food retention increased 36% (95% confidence interval 1.15-1.60) for every 1% increase in hemoglobin A1C after adjusting for GLP1-RA type and preoperative medication hold. DISCUSSION: In this multicenter study, very low rates of retained gastric contents were seen during endoscopy in patients on GLP1-RAs and most were in patients with type 2 diabetes mellitus. Our findings suggest an individualized approach rather than universal preoperative holding of medications before endoscopy.
引用
- Phan J, Chang P, Issa D, et al. Glucagon-Like Peptide Receptor Agonists Use Before Endoscopy Is Associated With Low Retained Gastric Contents: A Multicenter Cross-Sectional Analysis. Am J Gastroenterol. 2024. PMID: 39016372. doi:10.14309/ajg.0000000000002969
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。